Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Opex Pharmaceuticals To Build Houston Manufacturing Facility
Opexa Pharmaceuticals has selected PageSoutherlandPage Architects, Engineers, and Consultants of Houston to provide architecture, engineering, commissioning, and validation support services for Opexa’s new manufacturing facility. The 27,000-sf structure will include corporate offices and a new production facility to manufacture pharmaceuticals for autoimmune diseases, focusing on multiple sclerosis.
Sybase Occupies New Dublin Headquarters
Sybase, the e-business software and database maker, has relocated 1,000 employees from Emeryville, Calif., to its new 406,000-sf headquarters in Dublin. Wilcox Development Services developed the two-buildings, which are connected by a bridge. Administrative staff is housed in one building; engineering staff, a day care center and fitness center are housed in the other. The day care center, scheduled to open in March, will accommodate up to 52 children, whose parents can watch them via a Web cam.
Point Loma Nazarene Renovation Completed
Renovations to a 48,000-sf building have been completed at Point Loma Nazarene University's Mission Valley campus.
Lipomed To Occupy New Headuarters
LipoMed will consolidate its three Raleigh locations in a new headquarters for the biotech company at the Parker Business Center, where Phase I construction is complete. A nearby 40,000-sf shell building has been fitted-up and is ready for move-in. An adjacent 33,000-sf shell building will be upfitted, and a 12,000-sf connector built in Phase II of the project. LipoMed performs diagnostic testing of lipoproteins to determine heart disease risks.
Perkin Elmer Develops Billerica Manufacturing Facility
PerkinElmer Life Sciences, based in Boston, has a new 3,800-sf manufacturing building under construction in Billerica. The renovated space will accommodate 10-12 employees. The plant will produce Yttrium 90 for use in radiotherapeutic cancer treatment. It is anticipated that the facility will be operational in early 2002.